Skip to main content
Premium Trial:

Request an Annual Quote

Sitting Pretty


As genomics stocks bottom out, here’s who’s still on top

$7.1M William Rich, Ciphergen, CEO

$63.1M Mark Chandler, Luminex, CEO

$213.3M Lyle Turner, Invitrogen, CEO

$2.7M Mark Boguski, Rosetta Inpharmatics, Sr. VP of R&D

$6.9M William Matthews, Deltagen, CEO

$4.9M Mark Gessler, Gene Logic, CEO

$1.8M Stuart Collinson, Aurora Biosciences, CEO

$8.7M Howard Birndorf, Nanogen, CEO

$66.8M Mark Chee, Illumina, VP of Genomics

$76.0M Tony White, Applera, CEO

$5.3M Arthur sands, Lexicon Genetics, CEO

$6.3M Gregg Helt, Affymetrix, Principal Scientist

$1.3M Dale Pfost, Orchid BioSciences, President and CEO

$8.4M Cyrus Harmon, Affymetrix, VP of Computational Genomics

$1.7M John King, Rosetta Inpharmatics, COO

$9.7M Timothy Rink, Aurora Biosciences, Fmr. Chrm. and CEO

$40.5M Michael Hunkapiller, Applied Biosystems, President

$2.6M Tony Shuh, Sequenom, President and CEO

$4.1M Daniel Kisner, Caliper Technologies, CEO

$8.5M Stephen Fodor, Affymetrix, CEO

$1.1M Kieran Gallahue, Nanogen, CFO

$17.1M Roy Whitfield, Incyte Genomics, CEO

$42.2M Craig Venter, Celera Genomics, CSO

$15.3M Harden McConnell, Molecular Devices, Founder

$3.2M Calvin Chow, Caliper Technologies, COO

$3.9M Hannes Smarason, DeCode Genetics, Sr. Bus. & Finance Officer

$4.8M Joseph Keegan, Molecular Devices, CEO

$14.6M Emery Olcott, Packard Bioscience, CEO

$4.9M Joseph Limber, Aclara BioSciences, CEO

$18.4M Dennis Winger, Applied Biosystems, CFO

$2.9M Herbert Hooper, Aclara BioSciences, CSO

$38.8M Jeffrey Williams, Genomic Solutions, CEO

$21.9M Kari Stefansson, DeCode Genetics, CEO

$7.2M Jay Flatley, Illumina, CEO

$8.8M Randy Scott, Incyte Genomics, Chairman

$10.0M Richard McKernan, Packard BioScience, Sr. VP

$3.4M Jeffrey Gulcher, DeCode Genetics, VP, R&D

$5.9M Stephan Friend, Rosetta Inpharmatics, CEO

Values reflect individuals’ fully diluted company shares and options. All data based on most recent SEC filings available and March 29 share prices.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.